Clinical Trial Update: Study of TRX-920 for Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

TaiRx, Inc. is recruiting for a Phase 1 study of TRX-920 in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TRX-920

Snippet

Sponsor: TaiRx, Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING